[Effect of Risperidone on BDNF-TrkB Signaling Pathway in Rat Brain]

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Brain-derived neurotrophic factor (BDNF) plays a crucial role in neuronal survival and function.
• BDNF exerts its effects through receptors TrkB and P75NTR.
• Risperidone is an atypical antipsychotic used to treat various psychiatric disorders.

Purpose of the Study:

• To examine the impact of risperidone on BDNF, TrkB, and P75NTR expression in specific rat brain regions.
• To elucidate the signaling pathways modulated by risperidone.

Main Methods:

• Adult Sprague-Dawley rats were administered risperidone (0.25 mg/kg/day) or placebo for 14 days.
• Quantitative real-time PCR was used to measure mRNA expression of BDNF, TrkB, and P75NTR.
• Analysis focused on prefrontal cortex, temporal cortex, and hippocampus.

Main Results:

• Risperidone significantly upregulated BDNF and TrkB mRNA expression in all examined brain regions.
• No significant changes were observed in P75NTR mRNA expression following risperidone treatment.
• The findings indicate a selective modulation of BDNF signaling components.

Conclusions:

• Risperidone enhances the BDNF-TrkB signaling pathway in the rat brain.
• The drug does not appear to significantly affect the BDNF-P75NTR signaling pathway.
• These results provide insights into the neurobiological mechanisms of risperidone and may inform future pharmacological investigations.